TWI322816B - Peptide compounnds, and method of measuring sulfur compound and ammonia therewith - Google Patents
Peptide compounnds, and method of measuring sulfur compound and ammonia therewith Download PDFInfo
- Publication number
- TWI322816B TWI322816B TW98138602A TW98138602A TWI322816B TW I322816 B TWI322816 B TW I322816B TW 98138602 A TW98138602 A TW 98138602A TW 98138602 A TW98138602 A TW 98138602A TW I322816 B TWI322816 B TW I322816B
- Authority
- TW
- Taiwan
- Prior art keywords
- peptide
- ammonia
- compound
- sulfur
- detecting
- Prior art date
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 title claims description 100
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 78
- 229910021529 ammonia Inorganic materials 0.000 title claims description 49
- 150000003464 sulfur compounds Chemical class 0.000 title claims description 41
- 238000000034 method Methods 0.000 title claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 45
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical group CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000013078 crystal Substances 0.000 claims description 14
- 208000019425 cirrhosis of liver Diseases 0.000 claims description 13
- 206010016654 Fibrosis Diseases 0.000 claims description 11
- 230000007882 cirrhosis Effects 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 239000011593 sulfur Substances 0.000 claims description 10
- 239000010453 quartz Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 5
- 235000014102 seafood Nutrition 0.000 claims description 5
- 238000000018 DNA microarray Methods 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000004065 semiconductor Substances 0.000 claims description 2
- 238000010897 surface acoustic wave method Methods 0.000 claims description 2
- 239000013307 optical fiber Substances 0.000 claims 1
- 239000007789 gas Substances 0.000 description 20
- 150000001413 amino acids Chemical group 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 210000001331 nose Anatomy 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- KBMBVTRWEAAZEY-UHFFFAOYSA-N trisulfane Chemical compound SSS KBMBVTRWEAAZEY-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 102000012547 Olfactory receptors Human genes 0.000 description 4
- 108050002069 Olfactory receptors Proteins 0.000 description 4
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- -1 sulphur compound Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AZOFEHCPMBRNFD-BZSNNMDCSA-N Lys-Phe-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 AZOFEHCPMBRNFD-BZSNNMDCSA-N 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- XWKAVQKJQBISOL-UHFFFAOYSA-N 2-(phenylazaniumyl)propanoate Chemical compound OC(=O)C(C)NC1=CC=CC=C1 XWKAVQKJQBISOL-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- RKRSYHCNPFGMTA-CIUDSAMLSA-N Arg-Glu-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O RKRSYHCNPFGMTA-CIUDSAMLSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- PLOKOIJSGCISHE-BYULHYEWSA-N Asp-Val-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLOKOIJSGCISHE-BYULHYEWSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- BZTSQFWJNJYZSX-JRQIVUDYSA-N Thr-Tyr-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O BZTSQFWJNJYZSX-JRQIVUDYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000003875 Wang resin Substances 0.000 description 1
- NERFNHBZJXXFGY-UHFFFAOYSA-N [4-[(4-methylphenyl)methoxy]phenyl]methanol Chemical compound C1=CC(C)=CC=C1COC1=CC=C(CO)C=C1 NERFNHBZJXXFGY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- KIEKAILMEJNSKU-UHFFFAOYSA-N bis(sulfanyl) sulfate Chemical compound SOS(=O)(=O)OS KIEKAILMEJNSKU-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- HOBBGWUQJYXTQU-UHFFFAOYSA-N sulfurodithioic O,O-acid Chemical group OS(O)(=S)=S HOBBGWUQJYXTQU-UHFFFAOYSA-N 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- ATGUDZODTABURZ-UHFFFAOYSA-N thiolan-2-ylideneazanium;chloride Chemical compound Cl.N=C1CCCS1 ATGUDZODTABURZ-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
1322816 六、發明說明: 【發明所屬之技術領域】 本發明係有關於胜肽化合物,特別是有關於對肝硬化 患者呼氣中之硫類化合物及氨具有高鍵結敏感度和鍵結強 度,可用於檢測硫類化合物、氨及肝硬化等疾病狀況之胜 肽化合物。本發明亦有關於利用上述胜肽化合物檢測硫類 化合物及氨之方法。 【先前技術】 · 在哺乳動物的嗅覺系統中,位於鼻黏膜上具有嗅覺接 受蛋白被於細胞膜上,此嗅覺接受蛋白可以與氣體分子反 應後,將訊息經由一連串的生化反應傳至大腦的嗅覺區判 斷味道種類。嗅覺接受蛋白對不同的氣體分子具有不同的 鍵結位置,此完全取決於其氨基酸序列與所形成之立體結 構;本發明係以此為契子進而推論不同的胜肽序列對不同 的氣體分子或化合物具有不同的鍵結能力。即配合不同感 測功能,再設計不同的胜肽作為接受膜,而達到檢測特定 籲 化合物之目的。 在許多疾病狀態下,如肝硬化、肝病、牙酿炎等情況, 體内的硫類化合物會偏高;腎臟病、尿毒症、胃潰瘍等情 況,體内的氨含量會偏高,因此可藉由測量體内或呼出氣 體中之硫類化合物及氨的含量以判斷是否有此類疾病。另 外,海產如魚類、貝類的腐壞亦會釋放出氨,因此本發明 亦可應用於海產新鮮度的檢測。相同地,本發明亦適用於 空氣或水中硫類化合物及氨含量之檢測,進而判斷是否有 IS 1 4 1322816 空氣污染或水質污染的情況。 【發明内容】 本發明提供一種胜肽化合物,其對硫類化合物及氨具 有高敏感度及高鍵結強度,適用於硫類化合物及氨之檢 測。本發明之胜肽化合物特別適用於檢測肝硬化患者呼氣。 本發明亦提供以上述胜肽化合物檢測硫類化合物及氨 之方法,包括下列步驟:令一待測物質與一感測元件接觸, • 此感測元件上覆被有前述之胜肽化合物;處理所得之信 號;以及將信號與一資料庫比對,以定義待測物質中的硫 類化合物及氨的存在。 本發明亦提供一檢測硫類化合物及氨之裝置,包括一 個或多個感測元件,其上覆被有前文所述胜肽化合物,及 一信號處理單元搞接於該感測元件用以產生一信號。 本發明之胜肽序列對於硫類化合物及氨具有高敏感度 及高鍵結強度的特性,利用此胜肽序列或含有此胜肽之化 ® 合物作為與嗅覺閥值低的硫類化合物及氨反應或檢測的物 質,運用於感測器的檢測上,作為檢測硫類化合物及氨之 工具,具有提高敏感度及低濃度物質檢測適用性等特質。 為了讓本發明之上述和其他目的、特徵、和優點能更 明顯易懂,下文特舉較佳實施例,並配合所附圖示,作詳 細說明如下: 【實施方式】 為達以設計胜肽檢測硫類化合物之目的,可經由蛋白 質之二級結構分析胜肽序列特性或利用蛋白質之三級梦構 模擬與目標分子之鍵結位置或根據檢測物質之物性與化性 任意設計氨基酸之組合’進行胜肽序列設計,再以人工方 式加以合成;所得到之胜肽化合物配合感測元件或晶片將 訊號輸出,可用於硫類化合物’即含有-R-SH功能基團之 化合物,其中R為烷基基團(Alkyl group)或芳香基團(Aryi group),而對於含有氨(ammonia)、二甲美妒 (dimethylsulfide)、與二曱基硫:H20 =】, 1 · 1 (dimethylsulfide:H20 = 1:1)等化合物的檢測則是特別翁敏。 本發明之胜肽序列係擇自由下列族群中: 序列辨識號 1 : Gly-Asn-Thr_Tyr-Asp ; 序列辨識號 2 : Glu-Gly-Asn-Thr-Tyr-Asp ; 序列辨識號 3 : Lys-Phe-Lys-Glu-Val ; 序列辨識號 4 : Glu-Ser-Lys-Val-Tyr ; 序列辨識號 5 : Asp-Val-Asn-Tyr-Gly-Asn ;及 序列辨識號 6: Lys-Phe-Lys-Glu_Val-Thr-Arg-Glu-Asn。 i述胜狀序列可視需要在其羧酸端及/或氨基端加上 —iU复輿:個修傳基團,此修飾基團可為胺基酸或其它功能 基團’胺基駿如:胺基丙酸、精胺酸、天門冬醯胺、天門 冬胺酸、半耽胺酸、麩胺酸醯胺、麩胺酸、甘胺酸、組織 胺酸、異白胺酸、白胺酸、離胺酸、甲硫胺酸、苯胺基丙 酉文、捕胺酸、絲胺酸、息寧胺酸、色胺酸、酪胺酸、及纈 胺酸,功能基團則可擇自-COOH、-NH2、-CHO、-OH、或 SH。 H明之以胜肽化合物檢測硫類化合物及氨之方法, 1322816 • 係利用前文所述之胜肽化合物可與硫類化合物及氨所產生 鍵結作用的特性,而達到檢測樣本内硫類化合物及氨、其 液相、或其揮發性氣體之含量的目的。第1圖係本發明以 胜肽化合物檢測硫類化合物及氨之方法的流程圖,包括I 列步驟:以一感測元件感測一待測物質,此感測元件上覆 被有前述之胜肽化合物;處理所得之信號;以及將信號與 一已建立的資料庫比對,以定義待測物質中的硫類化合物 及氨之含量。硫類化合物在此是指具有-R-SH功能基團之 • 化合物’其中R為烷基基圑(Alkyl group)或芳香基團(Aryl group),例如具二曱基硫、二曱基硫:h20 = 1 : 1、及氨基 團之化合物。上述方法包括:在一感測元件上,固定前文 所述之胜肽化合物’使此感測元件與一樣本接觸,藉由# 測此胜肽化合物與硫類化合物及氨的結合,以檢測該樣本 所含之硫類化合物及氨之存在。其中可作為感測器者如化 學感測器、生物感測器或電子鼻的接受器、生物晶片,其 感測元件之傳導器(transducer)可為壓電石英晶體 _ (piezoelectric quartz crystal)、表面聲波(surface acoustic wave)、電化學(electrochemical)、光纖(fiber optic)、表面電 漿共振(surface plasmon resonance)、金屬氧化物半導體 (metal oxide semiconductor)。壓電晶體是一項近年頗受重 視的檢測工具之一,其接受器具有一石英晶體,其上覆被 以前述之胜肽化合物,當胜肽化合物與硫類分子反應時, 質量的改變便會影響石英晶體的頻率,故反應時的強度便 可根據石英晶體的頻率改變來指示。而本發明之胜肽序列 對硫類化合物及氨具有極佳的鍵結敏感度及鍵結強度’在 1322816 檢測硫類化合物及氨上提供極佳的敏感度。本發明之方法 . 中,受測之樣本可為氣體、液體或固體,舉例來說,如空 氣、水、海產、動物或人體的血液、尿液及呼氣等。 本發明檢測硫類之方法可應用的範圍相當廣泛,例如 可藉由檢測如,呼氣、血液或尿液等樣本中所含的硫類含 量而判斷其疾病狀態,此類疾病的例子有:肝硬化、肝病、 牙齦炎等症狀。本發明檢測氨之方法可應用的範圍,例如 可藉由檢測如,啤氣、血液或尿液等樣本中所含的氨含量 而判斷其疾病狀態,此類疾病的例子有:腎臟病、尿毒症 籲 及胃潰瘍。特別是肝硬化可直接藉測量患者呼出氣體的硫 類及氨化合物的濃度變化而檢測。本發明亦適用於海產新 鮮度檢測、空氣污染之檢測、及水質檢測。 本發明之檢測硫類化合物及氨之裝置,包括一感測元 件,其上覆被有前文所述胜肽化合物,及一信號處理單元 耦(接於該感測元件用以產生一信號。上述感測元件可為前 述應用各種物理、化學形式應用之傳感器或生物晶片。 為了進一步闡明本發明之方法、特徵、和優點,以下 籲 以電子鼻感測器,提出實施例作詳細說明如下: 發明人以嗅覺接受蛋白的立體結構為板模,利用電腦 軟體Insight II模擬與肝硬化患者呼氣作用的可能位置的胜 肽,再根據氨基酸之特性加以修飾此胜肽序列,透過以電 腦模擬設計對硫類化合物具有專一性、高靈敏度反應之胜 肽序列,將之作為電子鼻的接受膜,進而用於檢測具硫類 功能基團之化合物。電子鼻的傳導器(transducer)是採用 12MHz 壓電石英晶體(piezoelectric quartz crystal),再將設 m 8 1322816 計之胜肽覆被於石英晶體上’以電子鼻系統分析對硫類化 合物之反應。 【實施例】 製備例1 :胜肽之合成 本發明胜肽可以人工合成方式取得,如固相合成(solid phase synthesis)、液態胜肽合成(liquid peptide synthesis)、 酵素合成(enzymtic synthesis)、或DNA重組技術 (recombinant DNA technology)。本實施例依據固相合成, 以Wang resin為樹脂,F-moc為保護基,經由胜肽合成儀 (Apply Biosystems,432A Peptide Synthesizer,USA)合成。 製備例2 :修飾與覆被胜肽於壓電晶體金電極表面 設計胜肽序列時’利用硫可與金形成穩定的共價鍵, 利用Traut氏試劑(Traut’sreagent)將胜肽硫化後,依胜肽的 溶解度以適當的有機溶劑稀釋,覆被在具有金電極的壓電 晶體表面上。胜肽之覆被方式是取2_4以丨的溶液覆蓋於壓 電晶體之金電極上,於45七反應後,偵測頻率下降值至 15000 2GGGG Hz左右即可,但有些分子性質較特殊則依反 應結果調整覆被量。 製備例3 :揮發性氣體之製備 將試藥級二甲基胺、氨、丙酮、丁酸、及曱醛等化合 物各別溶於揮發性有機溶液5 m卜置於120 ml的密閉血清 1322816 瓶中’平衡5天至上部空間氣體達飽和蒸氣壓,由溶液的 濃度及飽和蒸氣壓值可換算得知上部空間氣體的濃度。依 測試所需’可利用上部空間氣體再稀釋使用或直接抽取分 析。 實施例1 :胜肽序列1-6 (序列辨識號1-6)對揮發性 氣體的反應 將胜肽序列1 (序列辨識號1)覆被於電子鼻壓電晶 體’藉助電子鼻分析系統(Smart Biotechnology Co.,Ltd., Taipei,Taiwan),對二曱基硫、二甲基硫:H20 = 1 : 1及氨 等三種硫類揮發性氣體,及其它上述之化合物的上部空間 揮發氣體個別進行反應,用於電子鼻分析之氣體約為5 mg/1左右,比較反應之專一性及靈敏度。 此六個胜肽覆被於電子鼻壓電晶體上的量,根據 Sauerbrey equation (Sauerbrey,1959),壓電晶體頻率下降值 與其上質量的改變成正比,故以胜肽覆被後之頻率下降值 (Hz)表示覆被量大小。本實施例中,胜肽序列1至6 (序列 辨識號1-6)之覆被量列於表1 : 表1 胜肽序列 1 (序列辨 識號1) 胜肽序列 2 (序列辨 識號2) 胜肽序列 3 (序列辨 識號3) 胜肽序列 4 (序列辨 識號4) 胜肽序列 5 (序列辨 識號5) 胜肽序列 6 (序列辨 識號6) 胜肽序 6442 31 4890 8750 883 1148 1322816 列覆被 量(Hz) 胜肽序列1至6 (序列辨識號1-6)對二曱基硫、氨、 丙酮、丁酸、及曱醛等有機揮發性氣體反應靈敏度之比較 則如第2圖所示。由第2圖中可以看出胜肽序列1及2(序 列辨識號1及2)對二曱基硫、二曱基硫:H20 = 1 : 1、及 氨的反應最明顯、專一性最佳,其中對氨的反應又特別顯 • 著,而對其他的有機揮發性氣體反應很差,顯示胜肽序列 1及2 (序列辨識號1及2)極適合用來檢測硫類及氨化合 物。胜肽序列3-6 (序列辨識號3-6)對二甲基硫:H20= 1 : 1及氨的反應最明顯、專一性最佳,顯示胜肽序列3-6 (序 列辨識號3-6)極適合用來檢測二曱基硫·· H20 = 1 : 1及 氨等化合物。 實施例2 :胜肽序列1-6 (序列辨識號1-6)對健康人 ® 及肝硬化患者呼氣之反應 肝硬化病人之哞氣含有多量的含硫化合物及氨。將在 中國醫藥學院收集的63個肝硬化病人呼氣氣體以及31個 健康人呼氣氣體藉由本發明之胜肽序列1-6 (序列辨識號 1-6),分別覆被於六個壓電晶體上,配合電子鼻分析系統 進行反應,比較肝硬化病人與健康人之呼氣氣體對與本發 明之胜肽序列的反應。反應結果由統計軟體 STATGRAPHICS Plus分析。利用本發明之胜肽序列進行呼 1322816 氣分析之結果如下所述:63位肝硬化患者中有60位(95.24 %)被判定為肝硬化患者,3位(4.76 %)被判定為正常;31 位健康人中有3位(9.68 %)被判定為肝硬化患者,28位 (90.32 %)被判定為正常;經由統計,本分析方法的準確度 高達93.62 %。由此可見本發明之胜肽化合物對於肝硬化患 者之判定確有其應用上的價值。 本發明亦適於以類似方法加以收集關於其它會導致呼 氣中硫類化合物及氨上升之疾病,如腎臟病、尿毒症、肝 | 病、牙齦炎及胃潰瘍等症狀之資料,建立對比資料庫,進 而應用於上述症狀的判定上。 雖然本發明已以較佳實施例揭露如上,然其並非用以 限定本發明,任何熟習此技藝者,在不脫離本發明之精 神和範圍内,當可作些許之更動與潤飾,因此本發明之 保護範圍當視後附之申請專利範圍所界定者為準。1322816 VI. INSTRUCTIONS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to peptide compounds, and more particularly to high bonding sensitivity and bonding strength to exhaled sulfur compounds and ammonia in patients with cirrhosis. It can be used to detect peptide compounds such as sulfur compounds, ammonia and liver cirrhosis. The present invention also relates to a method for detecting a sulfur compound and ammonia using the above peptide compound. [Prior Art] · In the mammalian olfactory system, the olfactory receptor protein is located on the cell membrane on the nasal mucosa. The olfactory receptor protein can react with the gas molecules to transmit the message to the olfactory region of the brain through a series of biochemical reactions. Determine the type of taste. The olfactory receptor protein has different bonding positions for different gas molecules, depending on its amino acid sequence and the formed steric structure; the present invention uses this as a deduction to infer different peptide sequences to different gas molecules or compounds. Have different bonding capabilities. That is, in combination with different sensing functions, different peptides are designed as a receiving membrane to achieve the purpose of detecting specific compounds. In many diseases, such as cirrhosis, liver disease, tooth brewing, etc., the sulfur compounds in the body will be high; kidney disease, uremia, stomach ulcers, etc., the body's ammonia content will be high, so you can borrow The content of sulfur compounds and ammonia in the body or exhaled gas is measured to determine whether there is such a disease. In addition, the destruction of seafood such as fish and shellfish also releases ammonia, so the present invention can also be applied to the detection of seafood freshness. Similarly, the present invention is also applicable to the detection of sulfur compounds and ammonia content in air or water to determine whether there is air pollution or water pollution of IS 1 4 1322816. SUMMARY OF THE INVENTION The present invention provides a peptide compound which has high sensitivity and high bonding strength to sulfur compounds and ammonia, and is suitable for detection of sulfur compounds and ammonia. The peptide compound of the present invention is particularly useful for detecting exhalation in a patient with cirrhosis. The present invention also provides a method for detecting a sulfur compound and ammonia by using the above peptide compound, comprising the steps of: contacting a substance to be tested with a sensing element, • coating the sensing element with the aforementioned peptide compound; The resulting signal; and aligning the signal with a database to define the presence of sulfur compounds and ammonia in the material to be tested. The present invention also provides a device for detecting a sulfur compound and ammonia, comprising one or more sensing elements overlying a peptide compound as described above, and a signal processing unit coupled to the sensing element for generating a signal. The peptide sequence of the present invention has high sensitivity and high bonding strength to sulfur compounds and ammonia, and the peptide sequence or the compound containing the peptide is used as a sulfur compound having a low olfactory threshold value and Ammonia reaction or detection substances are used in the detection of sensors. As a tool for detecting sulfur compounds and ammonia, they have the characteristics of improving sensitivity and applicability of low-concentration substances. The above and other objects, features, and advantages of the present invention will become more apparent and understood by the appended claims appended claims The purpose of detecting sulfur compounds is to analyze the sequence characteristics of the peptide via the secondary structure of the protein or to simulate the binding position of the target molecule with the tertiary structure of the protein or to arbitrarily design the combination of amino acids according to the physical properties and chemical properties of the detected substance. The peptide sequence is designed and synthesized manually; the obtained peptide compound is combined with a sensing element or a wafer to output a signal, and the sulfur compound can be used for a compound containing a -R-SH functional group, wherein R is Alkyl group or aromatic group (Aryi group), and for containing ammonia, dimethylsulfide, and dimercaptosulfide: H20 =, 1 · 1 (dimethylsulfide: H20 = 1:1) The detection of compounds is especially Wengmin. The peptide sequence of the present invention is selected from the following populations: Sequence ID: Gly-Asn-Thr_Tyr-Asp; Sequence ID 2: Glu-Gly-Asn-Thr-Tyr-Asp; Sequence ID 3: Lys- Phe-Lys-Glu-Val; SEQ ID NO: 4: Glu-Ser-Lys-Val-Tyr; SEQ ID NO: 5: Asp-Val-Asn-Tyr-Gly-Asn; and SEQ ID NO: 6: Lys-Phe- Lys-Glu_Val-Thr-Arg-Glu-Asn. The n-sequence sequence may optionally be added to the carboxylic acid end and/or the amino terminus by adding -iU retanning: a repairing group, which may be an amino acid or other functional group 'amine base such as: Alanine propionic acid, arginine, aspartate, aspartic acid, hemi-amic acid, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine , aminic acid, methionine, anilino-propionate, amino acid, serine, serotonin, tryptophan, tyrosine, and valine, functional groups can be selected from - COOH, -NH2, -CHO, -OH, or SH. H Mingzhi method for the detection of sulfur compounds and ammonia by peptide compounds, 1322816 • The use of the peptide compounds described above to bond with sulfur compounds and ammonia to achieve the detection of sulfur compounds in samples The purpose of the content of ammonia, its liquid phase, or its volatile gases. 1 is a flow chart of a method for detecting a sulfur compound and ammonia by a peptide compound, comprising the steps of I: sensing a substance to be tested by a sensing element, and the sensing element is overwritten by the foregoing. a peptide compound; processing the resulting signal; and aligning the signal with an established database to define the sulfur compound and ammonia content of the substance to be tested. The sulphur compound herein refers to a compound having a -R-SH functional group, wherein R is an Alkyl group or an Aryl group, for example, a dimercaptosulfuryl, a dimercaptosulfur :h20 = 1 : 1, and the compound of the amino group. The above method comprises: immobilizing a peptide compound as described above on a sensing element to bring the sensing element into contact with the same body, and measuring the combination of the peptide compound with a sulfur compound and ammonia to detect the The presence of sulfur compounds and ammonia in the sample. The sensor can be used as a sensor, such as a chemical sensor, a biosensor or an electronic nose receiver, a biochip, and the transducer of the sensing element can be a piezoelectric quartz crystal. Surface acoustic wave, electrochemistry, fiber optic, surface plasmon resonance, metal oxide semiconductor. Piezoelectric crystal is one of the most important testing tools in recent years. Its receptor has a quartz crystal, which is covered with the above-mentioned peptide compound. When the peptide compound reacts with the sulfur molecule, the quality changes. The frequency of the quartz crystal is affected, so the intensity at the time of the reaction can be indicated by the change in the frequency of the quartz crystal. The peptide sequence of the present invention has excellent bonding sensitivity and bonding strength to sulfur compounds and ammonia, and provides excellent sensitivity in the detection of sulfur compounds and ammonia in 1322816. In the method of the present invention, the sample to be tested may be a gas, a liquid or a solid, for example, air, water, seafood, blood of an animal or human body, urine, and exhalation. The method for detecting sulfur in the present invention can be applied to a wide range of applications, for example, by detecting the sulfur content contained in a sample such as exhalation, blood or urine, and examples of such diseases are: Symptoms such as cirrhosis, liver disease, and gingivitis. The method for detecting ammonia of the present invention can be applied, for example, by detecting the ammonia content contained in a sample such as beer, blood or urine, and examples of such diseases are: kidney disease, uremia Symptoms and stomach ulcers. In particular, cirrhosis can be detected directly by measuring changes in the concentration of sulfur and ammonia compounds exhaled by the patient. The invention is also applicable to seafood freshness detection, air pollution detection, and water quality detection. The device for detecting a sulfur compound and ammonia according to the present invention comprises a sensing element overlying a peptide compound as described above and a signal processing unit coupled to the sensing element for generating a signal. The sensing element can be a sensor or a biochip that is applied in various physical and chemical forms as described above. To further clarify the method, features, and advantages of the present invention, the following is an electronic nose sensor, and the following is described in detail as follows: The olfactory receptor accepts the three-dimensional structure of the protein as a plate model, and uses the computer software Insight II to simulate the peptides at the possible positions of exhalation in patients with cirrhosis, and then modify the peptide sequence according to the characteristics of amino acids, through computer simulation design. Sulfur compounds have a specific and highly sensitive peptide sequence, which is used as a receiving membrane for electronic noses, and is used to detect compounds with sulfur functional groups. The electron nose transducer is 12MHz piezoelectric. Pyroelectric quartz crystal, and then the peptide of m 8 1322816 is coated on the quartz crystal' The electronic nose system analyzes the reaction of sulfur compounds. [Examples] Preparation Example 1: Synthesis of peptides The peptides of the present invention can be obtained by artificial synthesis, such as solid phase synthesis, liquid peptide synthesis (liquid phase synthesis) Synthesis, enzymtic synthesis, or recombinant DNA technology. This example is based on solid phase synthesis, using Wang resin as the resin and F-moc as the protecting group, via the peptide synthesis instrument (Apply Biosystems, Synthesis of 432A Peptide Synthesizer, USA) Preparation 2: Modification and Overcoat Peptide Designing a Peptide Sequence on the Surface of a Piezoelectric Crystal Gold Electrode 'Using sulfur to form a stable covalent bond with gold, using Traut's reagent (Traut' Sreagent) After vulcanization of the peptide, the solubility of the peptide is diluted with an appropriate organic solvent and coated on the surface of the piezoelectric crystal with the gold electrode. The method of coating the peptide is to cover the piezoelectric solution with a solution of 2_4. On the gold electrode of the crystal, after the reaction at 45, the frequency of detection is reduced to about 15000 2GGGG Hz, but some molecular properties are more specific depending on the reaction result. Preparation Example 3: Preparation of Volatile Gas Compounds such as dimethylamine, ammonia, acetone, butyric acid, and furfural were dissolved in a volatile organic solution at a concentration of 5 m in 120 ml. In the sealed serum 1322816 bottle, 'balanced for 5 days to the upper space gas to reach a saturated vapor pressure, the concentration of the solution and the saturated vapor pressure value can be converted into the concentration of the upper space gas. Depending on the test required, the upper space gas can be used for further dilution or direct extraction analysis. Example 1: Reaction of peptide sequence 1-6 (SEQ ID NO: 1-6) on volatile gases Win peptide sequence 1 (SEQ ID NO: 1) was coated on an electronic nose piezoelectric crystal 'by means of an electronic nose analysis system ( Smart Biotechnology Co., Ltd., Taipei, Taiwan), three sulfur-based volatile gases such as dimercaptosulfur, dimethylsulfide: H20 = 1:1 and ammonia, and other space-evaporating gases of other compounds mentioned above. The reaction was carried out, and the gas used for electronic nose analysis was about 5 mg/1, and the specificity and sensitivity of the reaction were compared. The amount of the six peptides coated on the electronic nose piezoelectric crystal, according to the Sauerbrey equation (Sauerbrey, 1959), the piezoelectric crystal frequency drop value is directly proportional to the change in mass thereof, so the frequency after the peptide coating is decreased. The value (Hz) indicates the size of the overlay. In this example, the coverage of peptide sequences 1 to 6 (SEQ ID NO: 1-6) is shown in Table 1: Table 1 peptide sequence 1 (sequence number 1) peptide sequence 2 (sequence number 2) Peptide sequence 3 (SEQ ID NO: 3) peptide sequence 4 (SEQ ID NO: 4) peptide sequence 5 (SEQ ID NO: 5) peptide sequence 6 (SEQ ID NO: 6) peptide sequence 6442 31 4890 8750 883 1148 1322816 The ratio of the amount of (Hz) peptide sequence 1 to 6 (sequence number 1-6) is comparable to that of organic volatile gases such as dimercaptosulfur, ammonia, acetone, butyric acid, and furfural. The figure shows. It can be seen from Fig. 2 that the peptide sequences 1 and 2 (sequence number 1 and 2) have the most obvious reaction and the best specificity for dimercaptosulfuric acid, dimercaptosulfide: H20 = 1 : 1, and ammonia. Among them, the reaction to ammonia is particularly remarkable, and the reaction to other organic volatile gases is poor, indicating that peptide sequences 1 and 2 (SEQ ID NO: 1 and 2) are highly suitable for the detection of sulfur and ammonia compounds. The peptide sequence 3-6 (SEQ ID NO: 3-6) has the most obvious and specificity for dimethyl sulfide: H20 = 1:1 and ammonia, showing the peptide sequence 3-6 (SEQ ID NO: 3 - 6) It is very suitable for the detection of compounds such as dimercaptosulfur··H20 = 1: 1 and ammonia. Example 2: Response of peptide sequence 1-6 (SEQ ID NO: 1-6) to exhalation in healthy humans ® and patients with cirrhosis The hernias in patients with cirrhosis contain a large amount of sulfur-containing compounds and ammonia. The exhaled gas of 63 cirrhotic patients and 31 healthy human expiratory gases collected at the Chinese Medical College were respectively covered by six piezoelectrics by the peptide sequence 1-6 (sequence identification number 1-6) of the present invention. On the crystal, the reaction was carried out in conjunction with an electronic nose analysis system to compare the reaction of the expiratory gas of the patient with cirrhosis with a healthy person with the peptide sequence of the present invention. The reaction results were analyzed by the statistical software STATGRAPHICS Plus. The results of the gas analysis using the peptide sequence of the present invention were as follows: 60 of the 63 patients with cirrhosis (95.24%) were judged to be cirrhotic patients, and 3 (4.76%) were judged to be normal; Three (9.68%) of healthy people were judged to be cirrhotic patients, and 28 (90.32%) were judged to be normal; by statistical analysis, the accuracy of this analytical method was as high as 93.62%. Thus, it can be seen that the peptide compound of the present invention has practical application value for the judgment of patients with liver cirrhosis. The present invention is also suitable for collecting similar data on other diseases which may lead to exacerbation of sulfur compounds and ammonia, such as kidney disease, uremia, liver disease, gingivitis and gastric ulcer, and establish a comparative database. Further, it is applied to the determination of the above symptoms. While the present invention has been described in its preferred embodiments, the present invention is not intended to limit the invention, and the present invention may be modified and modified without departing from the spirit and scope of the invention. The scope of protection is subject to the definition of the scope of the patent application.
m 12 1322816 【圖式簡單說明】 第1圖:本發明以胜肽化合物檢測硫類化合物及氨 之方法的流程圖;及 第2圖:胜肽序列1-6 (序列辨識號1-6)對各種有 機揮發性氣體反應靈敏度之比較圖。 【主要元件符號說明】 無。m 12 1322816 [Simplified description of the drawings] Fig. 1 is a flow chart showing the method for detecting sulfur compounds and ammonia by the peptide compound of the present invention; and Fig. 2: Sequence of peptides 1-6 (SEQ ID NO: 1-6) A comparison of the sensitivity of various organic volatile gases. [Main component symbol description] None.
13 1322816 序列表 <110>財團法人工業技術研究院 < 12 0 >胜肽化合物及使用其檢測硫類化合物及氨之方法 <140> 90132419 <141〉90 年 12 月 26 日 <160> 6 <210> 1 <211〉 5 <212>胺基酸 <213>人工序列 <400> 113 1322816 Sequence Listing <110> Foundation Institute of Industrial Technology < 12 0 > peptide compound and method for detecting sulfur compound and ammonia <140> 90132419 <141> December 26, <;160> 6 <210> 1 <211> 5 <212> Amino acid <213> Artificial sequence <400>
Gly Asn Thr Tyr Asp 5 <210> 2 <211> 6 <212>胺基酸 <213>人工序列 <400> 2 1322816 . Glu Gly Asn Thr Tyr Asp • 1 5 <210> 3 <211〉 5 <212>胺基酸 <213>人工序列 <400>3Gly Asn Thr Tyr Asp 5 <210> 2 <211> 6 <212> Amino Acid <213> Artificial Sequence <400> 2 1322816 . Glu Gly Asn Thr Tyr Asp • 1 5 <210> 3 <211> 5 <212> Amino acid <213> Artificial sequence <400>3
Lys Phe Lys Glu Val ❿ 5 <210> 4 <211> 5 <212>胺基酸 <213〉人工序列 <400>4Lys Phe Lys Glu Val ❿ 5 <210> 4 <211> 5 <212> Amino Acid <213>Artificial Sequence <400>4
Glu Ser Lys Val Tyr • 1 5 <210> 5 <211〉 6 <212>胺基酸 <213>人工序列 <400>5Glu Ser Lys Val Tyr • 1 5 <210> 5 <211> 6 <212> Amino Acid <213> Artificial Sequence <400>5
Asp Val Asn Tyr Gly Asn 1322816 <210> 6 <211> 9 <212>胺基酸 <213>人工序列 <400>6Asp Val Asn Tyr Gly Asn 1322816 <210> 6 <211> 9 <212> Amino acid <213> Artificial sequence <400>6
Lys Phe Lys Glu Val Thr Arg Glu Asn 1 5Lys Phe Lys Glu Val Thr Arg Glu Asn 1 5
IS] 3IS] 3
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98138602A TWI322816B (en) | 2001-12-26 | 2001-12-26 | Peptide compounnds, and method of measuring sulfur compound and ammonia therewith |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98138602A TWI322816B (en) | 2001-12-26 | 2001-12-26 | Peptide compounnds, and method of measuring sulfur compound and ammonia therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201008955A TW201008955A (en) | 2010-03-01 |
| TWI322816B true TWI322816B (en) | 2010-04-01 |
Family
ID=44827651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW98138602A TWI322816B (en) | 2001-12-26 | 2001-12-26 | Peptide compounnds, and method of measuring sulfur compound and ammonia therewith |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI322816B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3098596B1 (en) * | 2019-07-12 | 2021-07-23 | Commissariat Energie Atomique | Detection system for electronic nose allowing physicochemical classification of odors and electronic nose comprising such a system |
-
2001
- 2001-12-26 TW TW98138602A patent/TWI322816B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW201008955A (en) | 2010-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Palladino et al. | Cardiac Troponin T capture and detection in real-time via epitope-imprinted polymer and optical biosensing | |
| Sun et al. | Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis | |
| TWI321569B (en) | Peptide and method for detecting amine using the same | |
| Gomara et al. | Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology | |
| US7579436B2 (en) | Peptide compound for measuring sulfur compound and ammonia | |
| Valencia et al. | Development of a bio-electrochemical immunosensor based on the immobilization of SPINNTKPHEAR peptide derived from HPV-L1 protein on a gold electrode surface | |
| JP2008076143A (en) | Instrument for measuring hemoglobin concentration | |
| JP2005538360A5 (en) | ||
| CN108957010A (en) | Paper-based sensor capable of detecting anaphylactic reaction and preparation and application thereof | |
| CN112375754B (en) | Severe acute respiratory syndrome coronavirus 2 affinity polypeptide based on human angiotensin converting enzyme 2 | |
| Han et al. | The design of anti-fouling and anti-hydrolysis cyclic peptides for accurate electrochemical antigen testing in human blood | |
| CN114324626A (en) | Characteristic peptide segment and method for detecting content of novel coronavirus spike protein | |
| TWI322816B (en) | Peptide compounnds, and method of measuring sulfur compound and ammonia therewith | |
| CN112300252B (en) | Prediction of 2019-nCoV coronavirus nucleocapsid protein epitope polypeptide and application of polypeptide in detection | |
| CN103562721B (en) | Method for immobilizing albumin on self-assembled monolayer | |
| TWI322817B (en) | Peptide compounnds, and method of measuring sulfur compound and ammonia therewith | |
| CN108519366A (en) | The method for detecting peptide using the compound substrate based on graphene | |
| TWI322819B (en) | Peptide and method for dectecing amine using the same | |
| US20080009070A1 (en) | Amine detecting method | |
| TWI322818B (en) | Peptide and method for dectecing amine using the same | |
| Braz et al. | A novel electrochemical immunosensor for the determination of tuberculosis diagnosis exploiting graphene-affinity peptide | |
| WO2004011948A1 (en) | Method of analyzing protein | |
| TWI252921B (en) | Bio-vehicle, biosensor and biotransducer system | |
| CN110257388A (en) | A kind of arginic polypeptide aptamers of specific recognition and application | |
| JP2008505073A5 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |